Sinopharm Capital helped supply funding to orthopaedic-focused device maker Suzhou and Science Technology Development, with the latter eyeing new products in areas including sports medicine.
Sinopharm Capital, the private equity arm of pharmaceutical company Sinopharm, has led a nine-figure renminbi (RMB100m = $14.9m) round for China-based orthopaedic medical device manufacturer Suzhou and Science Technology Development.
The round also featured venture capital firm Addor Capital and investment manager Caleb Capital according to China Money Network, which cited a company announcement. The round represents the first funding to be raised by the company.
Suzhou and Science Technology develops and markets orthopaedic medical devices which include a kyphoplasty…
